ERBB2 and melanoma: Furthermore, we demonstrated that differential expression of all investigated Ibrutinib target genes (i.e., BTK, EGFR, ERBB2, ITK, JAK3, and TEC) is associated with apoptotic mechanisms in clinical melanoma samples (Figure 7).